The EED gene helps switch other genes on and off at the right time, especially during early growth and brain development. If it does not work properly, body growth, learning, and development can be affected, and some people have a pattern of overgrowth with developmental delay or intellectual disability. Certain variants in the EED gene are also found in some cancers, where they may change how cells control growth.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or manage activities throughout the body. Some genes provide the directions for building proteins, which do much of the cell’s work. Others are used mainly to regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can also influence how you respond to food, stress, or medicines. For a closer look at this subject, you can find more in the LearnHub.
Overview
EEDGene function
What if the gene works
The EED gene helps control when other genes are turned on or off. This supports normal growth, early development, and how cells mature into their specialized roles.
Risk
What if the gene does not work
Changes in the EED gene can cause a growth and development condition with learning difficulties, larger body size, and distinctive facial features. Milder and more severe variants can influence which features appear and how early or strongly they show up.
Treatment
What does that mean for your treatment
No EED-specific treatment or drug choice is currently established for people with a pathogenic variant in the EED gene. In research, EED is being studied as part of the PRC2 pathway and as a possible drug target in some cancers, but this has not led to routine treatment changes for inherited EED-related conditions.
Conditions associated with EED
Gene function
What if the gene works
Your cells use the EED gene to manage which genes stay active and which stay quiet. This steady control matters during early growth and in everyday cell renewal. Understanding what the EED gene does in your cells helps explain how tissues keep their identity over time.
Inside a protein team, EED helps place and recognize small chemical tags on DNA packaging proteins. These tags help keep certain genes switched off when they are not needed.
By keeping the right genes quiet, the EED gene helps cells hold on to their job. For example, a skin cell can keep following a skin cell program instead of drifting toward a different one.
EED helps cells remember which genes should stay quiet after a cell divides. This supports stable patterns of gene activity as tissues renew themselves.
The EED gene supports the orderly timing of gene activity as tissues form and mature. This gives growing cells a more controlled sequence for when to pause, specialize, and keep routine functions running.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help account for normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant changes how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the EED gene can change how the EED protein folds, how stable it is, or how well it joins its protein team, which lowers its control over gene activity. This helps explain how EED gene variants affect function at the cellular level. Some variants only partly reduce activity, while more disruptive variants can greatly weaken or stop it. That difference can influence how strongly the related overgrowth condition shows up and when features begin.
How variants are linked to conditions
Pathogenic variants in the EED gene cause Cohen-Gibson syndrome, a rare overgrowth condition linked to taller growth, a larger head size, and developmental differences. The connection between the EED gene and Cohen-Gibson syndrome is well established, although features can vary from one person to another. A confirmed pathogenic variant in the EED gene can establish the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors play a part. In some situations, however, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risks related to the EED gene. In families with a disease-causing EED variant, risk is mainly shaped by the variant itself and family history rather than everyday lifestyle factors.
Inheritance of EED variants
For the condition most clearly linked to the EED gene, the inheritance pattern is autosomal dominant, which means a child can inherit the variant from one affected parent. In families with an inherited variant, each child has a 50% chance of receiving it. How EED gene variants are inherited also includes another well recognized pattern: some people have a new (de novo) variant that was not inherited from either parent. Once a person carries an EED-related dominant variant, they can pass it on to their children.
What does my EED result mean for my family?
For EED, a disease-causing result is most often linked to a dominant condition, which means close relatives such as parents, brothers, sisters, and children may also carry the same change. In families where a parent carries it, each child has a 1 in 2, or 50%, chance of inheriting it. Some EED changes happen for the first time in one person and are not inherited from either parent, so a parent is not always the source.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the EED gene, doctors use genetic testing for EED variants, usually from a blood sample or saliva. A lab reads the gene's DNA sequence to check for variants and compares the result with known clinically important changes. This can help clarify whether a condition linked to the EED gene is present.
When should I consider getting a genetic test?
Genetic testing for the EED gene may be worth considering when a child has unusual early overgrowth, a larger-than-average head size, and developmental or learning delays, especially if similar features run in the family. It can also help if a relative is already known to carry an EED change.
A genetic result is only one part of your health story
A genetic result can provide useful insight, though how much it explains depends on the specific condition and the type of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when considered alongside the rest of a person’s care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in a person’s DNA can change how the body breaks down a drug, moves it through the body, or responds to its effects at the target tissue. This helps explain why the same medication may work well for one person, do little for another, or cause more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape the way a person responds to medications. It studies links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body processes it. This information can support more informed and more individualized treatment decisions. If you want to explore this topic in greater detail, you can learn more in the LearnHub.
Drugs influenced by the EED gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work or which dose is best. Questions about side effects, treatment choices, or changes after starting a medicine are best discussed with your doctor.
History
The EED gene entered medical research through studies of early development and gene control, first in animal models and later in people. Initially understood only through visible traits, later recognized as tied to a specific gene, EED became part of a broader effort to map the genes involved in rare growth and developmental conditions. Building on this early work, scientists connected changes in the EED gene with a condition now known as Cohen-Gibson syndrome. Its role also drew attention because EED works within the same pathway as several other genes linked to human growth patterns. Over time, descriptions became more precise as DNA testing improved and helped confirm which variants were truly disease causing. Today, the EED gene is mainly known in clinical genetics through that progress in rare disease diagnosis.